Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss
Petriti, B., Rabiolo, A., Chau, K-Y. , Williams, P. A., Montesano, G. ORCID: 0000-0002-9148-2804, Lascaratos, G. & Garway-Heath, D. F. (2024). Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss. Nature Medicine, 30(8), pp. 2362-2370. doi: 10.1038/s41591-024-03068-6
Abstract
Intraocular pressure (IOP) is currently the only modifiable risk factor for glaucoma and all licensed treatments lower IOP. However, many patients continue to lose vision despite IOP-lowering treatment. Identifying biomarkers for progressive vision loss would have considerable clinical utility. We demonstrate that lower peripheral blood mononuclear cell (PBMC) oxygen consumption rate (OCR) is strongly associated with faster visual field (VF) progression in patients treated by lowering IOP (P < 0.001, 229 eyes of 139 participants), explaining 13% of variance in the rate of progression. In a separate reference cohort of untreated patients with glaucoma (213 eyes of 213 participants), IOP explained 16% of VF progression variance. OCR is lower in patients with glaucoma (n = 168) than in controls (n = 50; P < 0.001) and is lower in patients with low baseline IOP (n = 99) than those with high baseline IOP (n = 69; P < 0.01). PBMC nicotinamide adenine dinucleotide (NAD) levels are lower in patients with glaucoma (n = 29) compared to controls (n = 25; P < 0.001) and strongly associated with OCR (P < 0.001). Our results support PBMC OCR and NAD levels as new biomarkers for progressive glaucoma.
Publication Type: | Article |
---|---|
Additional Information: | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
Publisher Keywords: | Neurodegeneration, Prognostic markers |
Subjects: | R Medicine > R Medicine (General) R Medicine > RE Ophthalmology |
Departments: | School of Health & Psychological Sciences School of Health & Psychological Sciences > Optometry & Visual Sciences |
SWORD Depositor: |
Available under License Creative Commons: Attribution International Public License 4.0.
Download (3MB) | Preview
Export
Downloads
Downloads per month over past year